Evidence for a remarkable structural diversity of amyloid fibrils in human and animal tissue

March 15, 2016
Evidence for a remarkable structural diversity of amyloid fibrils in human and animal tissue

Formation of amyloid fibrils is a characteristic feature of neurogenerative diseases like Alzheimer's. As published in the journal Angewandte Chemie, German and American scientists have found evidence that these fibrils adopt several distinct three-dimensional architectures in real patient and animal tissues.

If a protein misfolds, it is usually readily degraded into its harmless components by special proteolytic enzymes in the cell. However, under certain pathologic conditions, some proteins or polypeptide chains can form aggregates that stack together in very stable fibrils, the most prominent forms being the amyloid fibrils found in the brain tissue of Alzheimer' s patients. These fibrils can have different morphologies varying lengths and widths and in the structure of the crossover region where the polypeptides entangle. However, that was found for laboratory-grown samples, but do these morphologies also occur in real tissue? A team of scientists at research institutes in Germany and the United States led by Marcus Fändrich at Ulm University have thoroughly investigated extracts from animals and patients suffering from different forms of amyloidosis and found that yes, they do. Their result has important applications for possible treatment scenarios.

In general, amyloid fibrils can be detected by dye binding, and special give insight into the folding pattern of the proteins. However, this may not be enough for distinguishing these morphologies. "Such intra-sample polymorphism can be invisible to spectroscopic techniques and requires single-particle techniques," the authors say. Therefore, Fändrich and his colleagues employ electron microscopy techniques to identify the morphologies.

They extracted and investigated amyloid fibril structures from real diseased tissues. The first examples were taken from the hearts of two individuals suffering from so-called light-chain amyloidosis. The fibrils displayed at least two morphologies, the scientists found. "Morphology I is thinner, while morphology II presents a more clearly resolved crossover structure," they write. The same was true for another sample from a patient who suffered from a transthyretin-amyloidosis, and also for animal samples like goat and mouse. All extracted fibril samples contained the fibrils in various and distinguishable shapes. Thus the scientists conclude: "The within a diseased individual can vary considerably in their three-dimensional architecture."

This result of pathogenic polymorphism within one individual is very important because it has impact on possible personalized medicine approaches for those forms of amyloidosis where the prove fatal: As patients develop more than one fibril structure, treatment of only a single fibril form would not be effective.

Explore further: Amyloid formation may link Alzheimer disease and type 2 diabetes

More information: Karthikeyan Annamalai et al. Polymorphism of Amyloid Fibrils In Vivo, Angewandte Chemie International Edition (2016). DOI: 10.1002/anie.201511524

Related Stories

A DNA-made trap may explain amyloidosis aggravation

October 9, 2012

Amyloidosis is a group of clinical syndromes characterized by deposits of amyloid fibrils throughout the body. These fibrils are formed by aggregates of proteins that have not been properly folded. Deposits of amyloid fibrils ...

Recommended for you

Bacteria development marks new era in cellular design

December 11, 2017

Scientists at the universities of Kent and Bristol have built a miniature scaffold inside bacteria that can be used to bolster cellular productivity, with implications for the next generation of biofuel production.

Molecular beacon signals low oxygen with ultrasound

December 8, 2017

Areas of hypoxia, or low oxygen in tissue, are hallmarks of fast-growing cancers and of blockages or narrowing in blood vessels, such as stroke or peripheral artery disease. University of Illinois researchers have developed ...

Targeting cancer cells by measuring electric currents

December 8, 2017

EPFL researchers have used electrochemical imaging to take a step forward in mapping the distribution of biomolecules in tissue. This technology, which uses only endogenous markers – rather than contrast agents – could ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.